European Journal of Clinical Pharmacology

, Volume 18, Issue 6, pp 473–477 | Cite as

Rapid prediction of steady-state serum theophylline concentration in patients treated with intravenous aminophylline

  • S. Vozeh
  • G. Kewitz
  • M. Wenk
  • F. Follath
Original

Summary

In 15 acutely ill asthmatics the steady-state serum theophylline concentration was predicted by the method of Chiou et al. using two serum concentration measurements obtained 1 and 5h after starting a continuous infusion of aminophylline. Two theophylline assays with different precision characteristics were compared. With a precise HPLC-assay the prediction was excellent: prediction error (predicted minus measured concentration)=−0.22±1.97 mg/l (mean ± SD); r=0.922. When the theophylline concentration was determined by a rapid enzyme immunoassay of lower precision, but convenient for clinical use, the prediction was less accurate (prediction error=0.58±3.88, r=0.852). However, it was still clearly superior to dosing recommendations based on the population average of theophylline clearance, even after taking into consideration the effect of smoking, congestive heart failure and cirrhosis (prediction error=3.62±13.36, r=0.560). As employed in this study, the method may be useful in helping the physician to choose the optimal dose in severely ill asthmatics.

Key words

aminophylline asthma serum theophylline pharmacokinetics prediction of serum level 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Piafsky KM, Sitar DS, Rangno RE, Ogilvie RJ (1977) Theophylline disposition in patients with hepatic cirrhosis. N Engl J Med 296: 1495–1497PubMedGoogle Scholar
  2. 2.
    Powell JR, Vozeh S, Hopewell P, Costello J, Sheiner LB, Riegelman S (1978) Theophylline disposition in acutely ill hospitalized patients. Am Rev Respir Dis 118: 229–238PubMedGoogle Scholar
  3. 3.
    Snider GL (1978) The treatment of asthma. N Engl J Med 298: 397–399PubMedGoogle Scholar
  4. 4.
    Hendeles L, Weinberger M (1979) Guidelines for avoiding theophylline overdose. N Engl J Med 300: 1217Google Scholar
  5. 5.
    Chiou WL, Gadalla MAF, Peng GW (1978) Method for the rapid estimation of the total body clearance and adjustment of dosage regimens in patients during a constant rate intravenous infusion. J Pharmacokinet Biopharm 6: 135–151PubMedGoogle Scholar
  6. 6.
    Mangione A, Imhoff TE, Lee RV, Shum LY, Jusko WJ (1978) Pharmacokinetics of theophylline in hepatic disease. Chest 73: 616–622PubMedGoogle Scholar
  7. 7.
    Jusko WJ, Gardner MJ, Mangione A, Schentag JJ, Koup JR, Vance JW (1979) Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. J Pharm Sci 68: 1358–1366PubMedGoogle Scholar
  8. 8.
    Vozeh S, Kewitz G, Perruchoud A, Tschan M, Kopp C, Herzog H, Follath F (1980) Theophylline serum concentration and the therapeutic effect in patients with acute exacerbation of bronchial obstruction. Presented at the annual meeting of the Swiss Medical Society, Lugano, SwitzerlandGoogle Scholar
  9. 9.
    Vozeh S, Powell JR, Riegelman S, Costello JF, Sheiner LB, Hopewell PC (1978) Changes in theophylline clearance during acute illness. J Am Med Assoc 240: 1882–1884Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • S. Vozeh
    • 1
  • G. Kewitz
    • 1
  • M. Wenk
    • 1
  • F. Follath
    • 1
  1. 1.Division of Clinical PharmacologyDepartment of Medicine Kantonsspital BaselSwitzerland

Personalised recommendations